Andere Sprachen Amicus Therapeutics, Inc.

Aktien

A0MSMZ

US03152W1099

FOLD

Realtime-Estimate Cboe BZX Andere Börsenplätze 18:00:26 01.05.2024			% 5 Tage	% 1. Jan.
10,12 ^USD	+1,30 %		-3,70 %	-28,47 %

18.03.	AMICUS THERAPEUTICS, INC. : JPMorgan Chase bekräftigt seine Kaufempfehlung	ZM
05.03.	Amicus Therapeutics Insider verkaufte Aktien im Wert von $389.543, laut einer aktuellen SEC Einreichung	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024	13:01
Amicus Therapeutics : ESG Report	20.03.
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report	20.03.
Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing	05.03.
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024	04.03.
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024	01.03.
Amicus Therapeutics Swings to Q4 Earnings, Revenue Rises	28.02.
Earnings Flash (FOLD) AMICUS THERAPEUTICS Posts Q4 EPS $0.01, vs. Street Est of $-0.04	28.02.
Amicus Therapeutics, Inc. Provides Earnings Guidance for the Year 2024	28.02.
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates	28.02.
Amicus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.02.
Amicus Therapeutics : Fourth Quarter and Full Year 2023 Results Conference Call and Webcast	28.02.
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024	15.02.
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti + Opfolda at the 20th Annual WORLDSymposium	09.02.
Amicus Therapeutics Insider Sold Shares Worth $390,018, According to a Recent SEC Filing	08.02.
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™	08.02.
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024	01.02.
Amicus Therapeutics Insider Sold Shares Worth $683,958, According to a Recent SEC Filing	24.01.
Amicus Therapeutics Insider Sold Shares Worth $404,106, According to a Recent SEC Filing	18.01.
Amicus Therapeutics Insider Sold Shares Worth $934,659, According to a Recent SEC Filing	12.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Amicus Therapeutics, Inc.

Aktien

A0MSMZ

US03152W1099

FOLD

Andere Sprachen

Filter